China Pranlukast Market Size & Outlook, 2026-2034


China Pranlukast Market Insights

  • Based on Reed Intelligence findings, the China Pranlukast Market reached USD 53.19 Billion in 2025 and is estimated to attain USD 115.83 Billion by 2034.
  • From 2026 to 2034, the China market is expected to grow at a steady CAGR of 8.99%.
  • Within the Formulation Type category, Tablets dominated in 2025 in terms of market size contribution.
  • Over the forecast period, Oral Suspensions is forecasted to deliver the fastest growth, positioning it as the most lucrative Formulation Type segment.

Other Key Findings


  • China accounted for 7.17% of the global Pranlukast Market size in 2025.
  • By 2034, United States is expected to remain the top global market in terms of size.
  • Within Asia Pacific, China is forecasted to dominate the regional Pranlukast Market size by 2034.
  • Taiwan will be the fastest-growing market in Asia Pacific, projected to achieve USD 15.13 Billion by 2034.

Report Summary

Report Scope Details
Base Year for Study 2025
Study Period 2022-2034
Historical Period 2022-2024
Forecast Period 2026-2034
Market Size In 2025 USD 53.19 Billion
Market Size In 2034 USD 115.83 Billion
Largest segment Tablets
Units Revenue in USD Billion
CAGR 8.99% (2026-2034)
Segmnetation Covered
Formulation Type
  1. Tablets
  2. Capsules
  3. Oral Suspensions
  4. Others
Application
  1. Asthma Treatment
  2. Allergic Rhinitis Treatment
  3. Bronchitis Management
  4. Others
Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
  4. Drug Stores
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends